scholarly journals DETEKSI DINI KANKER SERVIKS DENGAN PEMERIKSAAN SERVIKS DI KELURAHAN BULURAN KENALI KOTA JAMBI TAHUN 2017

2019 ◽  
Vol 1 (1) ◽  
pp. 56
Author(s):  
Julaecha Julaecha ◽  
Nurfitriani Nurfitriani

Cervical cancer is a malignant disease that occurs in the cervik. Course of the disease is preceded by the condition of pre-concerous lesions of the cerviks is the existence of dysplasi/cervical intraepithelial neoplasia (NIS). On each day is expeced to 40-45 new cases and about 20-25 people  die from cervical cancer. Based on those considered very necessary to provide education  on cervical cancer in women of reproductive age in the prevention of cervical cancer prevention effort.Target outcomes expected are: there is an increased knowledge an increase in knowledge between before and after extension and capable of early detection of cancer  serviks increase. Implementation method to provide counseling.The results  showed that there was important of mother’s interest in doing pap smears examination before and after counseling.

Author(s):  
Shafag Eldar Aliyeva ◽  

Introduction. According to modern data, cervical diseases do not occur by chance. Precancerous lesions vary from person to person and become invasive over time. The need for specific diagnostic methods for early detection of cervical cancer in women of reproductive age always remains relevant. Over the years, numerous diagnostic, cytological and histological studies have been carried out to identify malignant lesions of the cervix. Human papillomavirus (HPV) is a widespread sexually transmitted infection that affects both women and men around the world and plays an important role in the development of cervical disease. It is the most common sexually transmitted virus in the United States of America. For the first time in 1942, Papanicolaou emphasized the possibility of using smears (PAP smears) from the cervix and from the vagina to diagnose cervical disease. PAP preparations of smears are mainly multilayered flat epithelial cells of the ectocervix and vagina, endocervical cylindrical cells, including mononuclear and polynuclear inflammatory cells that enter the vagina through diapedesis from the surface of the epithelial layer, mixing with the mucoid fluid produced by the endocervical epithelial fluid. Purpose — using objective criteria for cytological examination to identify neoplastic changes in the cervix. Materials and methods. The study included 100 women of reproductive age (18–45 years old) during 2015–2020. Of these, 20 were in the control group (group I — control) and 80 — in the high-risk group for cervical cancer (group II — the main group). Group II women were also divided into 2 subgroups: II A — with pathology of the cervix (n=41), II B — without pathology of the cervix (n=39). The study included patients with a positive result on HPV 16/18 including patients whose PAP smears revealed intracellular damage. Pap smears were included in the study according to the following criteria. The smears contained a sufficient number of squamous epithelial cells and their integrity was preserved. Endocervical cells were monitored in all PAP smears. The examination was carried out with at least 5 cells in each, not completely, and with 2 clusters of endocervical glandular or squamous metaplastic cells. Squamous epithelial cells covered at least 10% of the preparation. Bloody, technically artifactic preparations without clinical data have not been studied. The deficit rate did not exceed 3%, and high interest rates on artifacts were not included in the study. Despite the small number of cells in the presence of abnormal cells, this was unequivocally considered sufficient. Results. Interpretation of PAP smear results identified n=35 ASCUS patients, n=24 LSIL, n=21 HSIL patients in the PAP smear positive reproductive age group. HPV serotypes 16.18 were found in 24 of these patients. In women of the II B subgroup, no pathological changes in the cervix were observed. Conclusions. In women of reproductive age with positive HPV 16, 18, for the diagnosis of precancerous diseases of the cervix, taking pap smears is an integral part of the study. As a result of the study, it was revealed that, despite the absence of a clinical picture, pathological changes at the cell level are detected. Key words: HPV16, 18, ASCUS, LSIL, HSIL, PAP.


2020 ◽  
pp. 107-112
Author(s):  
T. M. Harelik ◽  
I. A. Naumov

Objective: to develop a healthcare organizational model of secondary prevention of cervical cancer. Material and methods. The work analyzes the quality of medical care given to women of reproductive age living in Grodno region in whom cases of cervical intraepithelial neoplasia and cervical cancer were detected from 2010 to 2019. On the basis of the results of questioning of 200 women who had been treated in Oncology Ward No.3 of Grodno University Clinic, the most significant risk factors of the development of the pathology were identified. Statistical processing was performed by means of the program «Statistica» 10.0.Results. An effective model of secondary prevention of cervical cancer has been developed: from 2015 to 2019 compared to the previous quinquennium the detectability of cervical intraepithelial neoplasia and non-invasive cervical cancer increased by more than 17 % and 25 %, and the average parameters of the newly diagnosed morbidity were 69.97 ± 2.42 and 19.91 ± 2.28 per 100,000 women of reproductive age (p < 0.05). This made it possible to take timely measures for carcinogenesis interruption.Conclusion. The implementation of the healthcare organizational model of secondary prevention of cervical cancer contributes to improvement of the quality of medical care, and, therefore, maintainance of perspective realization of the child-bearing function for women of reproductive age.


2017 ◽  
Vol 11 (2) ◽  
pp. 49-54
Author(s):  
Chusnul Khotimah ◽  
Dyah Noviawati Setya Arum ◽  
Munica Rita Hernayanti

Cervical cancer is the second most common cancer in the world. In developing countries still ranks first as a cause of cancer deathsin women of reproductive age. Pap smear has proved very useful for early detection of cervical cancer since pre-cancerous stage,but many women are reluctant to undergo a pap smear because of ignorance, shame, fear, and cost factors. While the Pap smearcoverage lowest in Imogiri health center II is 0%. The type of research is a descriptive study with cross-sectional approach. Todescribe the level of knowledge and overview of the implementation of Pap smears in women in fertile age couple in the KemasanHamlet Karang Tengah Village Imogiri Bantul. The entire population of mothers in fertile age couple who attended of the PKK andwilling to become respondents in the Kemasan Hamlet Karang Tengah Village Imogiri Bantul. The results of research that themajority of respondents aged> 35 years (51.1%), basic education (50%), does not work (53.44%), obtain resources through onesource (63.3%). The level of knowledge about Pap smears in women PUS (Pasangan Usia Subur) in the Kemasan Hamlet KarangTengah Village Imogiri Bantul 2015 is in the category enough that 72.7% and most did not carry out pap smear that is, 86.4%. Theconclusion that the level of knowledge about the EFA mother pap smear EFA in the Kemasan Hamlet Karang Tengah Village ImogiriBantul 2015 enough and did not carry out pap smear.


2018 ◽  
Vol 26 (2) ◽  
pp. 149-152 ◽  
Author(s):  
Ashley Langell ◽  
Timothy Pickett ◽  
Catherine Mangum ◽  
Jennwood Chen ◽  
John Langell

Background. Cervical cancer remains a leading cause of cancer-related deaths worldwide despite being a highly preventable disease. Nine out of every 10 deaths due to cervical cancer occur in developing regions with limited access to medical care and unique resource constraints. To address cervical cancer prevention within the confines of these unique limitations, our team of students and faculty advisors at the University of Utah’s Center for Medical Innovation developed a low-cost, portable technology that utilizes thermal coagulation, a form of heat ablation, to treat cervical intraepithelial neoplasia. Methods. A multidisciplinary team of students worked with clinical and industry advisors to develop a globally applicable treatment for cervical intraepithelial neoplasia through a systematic process of problem validation, stakeholder analysis, user-centered design, business plan development, and regulatory clearance. Results. Our efforts resulted in the development of a functional, self-contained, battery-operated prototype within 72 days, followed by Food and Drug Administration clearance of a finalized device within 18 months. Conclusion. Interdisciplinary university programs that leverage the capabilities of academic-industry partnerships can accelerate the development and commercialization of affordable medical technologies to solve critical global health issues.


2020 ◽  
Vol 1 (1) ◽  
pp. 1-4
Author(s):  
Lia Artika Sari ◽  
Enny Susilawati

ABSTRAK Latar Belakang: Kanker merupakan salah satu penyebab kematian yang paling utama di dunia, sekitar 40 wanita tiap harinya terdiagnosa kanker leher rahim. Kanker leher rahim disebabkan oleh virus HPV, infeksi HPV sendiri sering kali tidak menimbulkan gejala. Desa Suka Maju merupakan salah satu desa yang terdapat di Kabupaten Muaro Jambi dan mempunyai jumlah wanita usia subur berjumlah 820 orang, namun hanya 17,11% wanita usia subur yang baru memanfaatkan pelayanan IVA.Metode: Dengan memberikan penyuluhan kepada wanita usia subur dengan (WUS) sebanyak 40 orang, dan diberikan pre dan post test untuk mengevaluasi pengetahuan wanita usia subur mengenai pemeriksaan IVA Hasil: terjadi kenaikan pengetahuan wanita usia subur di Desa Sukamaju sebesar 87,5%.Kesimpulan: Penyuluhan dapat meningkatkan pengetahuan wanita usia subur terhadap pentingnya pemeriksaan IVA. ABSTRACT Background: Cancer is one of the most common causes of death in the world. About 40 women are diagnosed with cervical cancer every day. Cervical cancer is caused by the HPV virus, HPV infection itself often causes no symptoms. Suka Maju Village is one of the villages in Muaro Jambi Regency that has 820 women of childbearing age, but only 17.11% of women of childbearing age have just used IVA services.Methods: employed in community service was to provide counseling to women of reproductive age with (WUS) as 40 women, and then given pre and posttests to evaluate the knowledge of women of childbearing age After being given counseling on IVA examinations. In brief,Result: There was an increase in the knowledge of women of childbearing age in Sukamaju Village by 87.5 %. Conclusion: Health education can increasedthe knowledge of women of childbearing age on the importance of IVA Chencking


2012 ◽  
Vol 29 (4) ◽  
pp. 213-218
Author(s):  
F Hussain ◽  
MS Flora ◽  
K Nahar ◽  
M Khan

Background: The field of cervical cancer prevention is  rapidly evolving because of identification of Human  Papilloma Virus (HPV) as the necessary cause of disease.  HPV vaccines are now in the market. For successful  triggering of cervical cancer prevention program, HPV  informations should be communicated to health care  providers whose understanding about HPV has lagged  behind the scientific and technical advances.Objective: The objective of this intervention study was to  identify gap and educate health care providers delivering  services to women and adolescents in Medical Colleges on  HPV related issues and vaccination.Methods: The study was done from July 2007 to June 2008  where 3 advocacy workshops were conducted. The  knowledge level of 106 participants were assessed before  and after intervention. Updated informations about HPV  and vaccine was given to participants as intervention.Results: Wide knowledge gap was identified among  participants on HPV related insues, but significant  improvement was observed following intervention. The  pretest and post test score of knowledge was 28.09 and 38.60  respectively showing an average increase of 10 after  intervention.Conclusions: HPV education should be extensively  disseminated to health care providers to obtain public health  benefits of HPV vaccination program. DOI: http://dx.doi.org/10.3329/jbcps.v29i4.11329 J Bangladesh Coll Phys Surg 2011; 29: 213-218


2016 ◽  
Vol 5 (3) ◽  
Author(s):  
Septia Haryani ◽  
Defrin Defrin ◽  
Yenita Yenita

AbstrakKanker serviks menempati urutan pertama penyebab kematian akibat kanker pada wanita usia reproduktif di negara berkembang. Jumlah paritas di Sumatera Barat masih cukup tinggi, paritas merupakan salah satu faktor risiko terjadinya kanker serviks yang berhubungan dengan hormon dan trauma saat persalinan. Tujuan penelitian ini adalah mengetahui prevalensi kanker serviks berdasarkan jumlah paritas di RSUP. DR. M. Djamil Padang. Penelitian ini merupakan penelitian deskriptif observasional. Data sekunder diambil dari rekam medik pasien kanker serviks di RSUP.Dr. M. Djamil Padang periode Januari 2011- Desember 2012. Penelitian ini dilakukan dari Oktober 2013 - Juni 2014. Pada penelitian ini didapatkan 63 kasus kanker serviks. Distribusi kanker serviks berdasarkan umur terbanyak pada kelompok umur >50 tahun sebanyak 27 kasus (42,9%), berdasarkan jenis pembayaran pasien kanker serviks banyak memakai jamkesmas sebanyak 21 kasus (38,1%), jenis histopatologi terbanyak ditemukan pada jenis karsinoma sel skuamosa sebanyak 46 kasus (73%) dan jumlah paritas yang terbanyak pada kelompok paritas 3-5 kali sebanyak 40 kasus (63,5%). Umur dan paritas tidak ada hubungannya dengan jenis kanker serviks.Paritas bukan merupakan faktor risiko terjadinya kanker serviks.Kata kunci: kanker serviks, paritas, histopatologi AbstractThe cervical cancer is the  first rank cause of cancer death in women of reproductive age in developing countries. The number of parity in West Sumatera is still high, parity is one of the risk factors for cervical cancer relating to hormone and birth trauma. The objective of this study was to identify the prevalence of cervical cancer based on parity in  Dr. M. Djamil Hospital Padang. This research was descriptive observational study. Secondary data was taken from medical record of cervical cancer patients in Dr. M.Djamil Hospital Padang from January 2011 until  December 2012. The study was held from October 2013 until June 2014.The research found 63 cases of cervival cancer. Distribution cervical cancer by the age of majority in the age group >50 years old were 27 cases (42,9%), based on kind of payment is mostly used jamkesmas were 21 cases (38,1%), based on histopathology of majority on squamous cell carcinoma is 46 cases (73%) and based on the highest number of parity is the parity group 3-5 were 40 cases (63,5%). People’s age and parity are not related to the type of cervical cancer. Parity is not a risk factor of having cervical cancer.Keywords: cervical cancer, parity, histopathology


BMJ ◽  
2019 ◽  
pp. l1161 ◽  
Author(s):  
Tim Palmer ◽  
Lynn Wallace ◽  
Kevin G Pollock ◽  
Kate Cuschieri ◽  
Chris Robertson ◽  
...  

Abstract Objective To quantify the effect on cervical disease at age 20 years of immunisation with bivalent human papillomavirus (HPV) vaccine at age 12-13 years. Design Retrospective population study, 1988-96. Setting National vaccination and cervical screening programmes in Scotland. Participants 138 692 women born between 1 January 1988 and 5 June 1996 and who had a smear test result recorded at age 20. Main outcome measures Effect of vaccination on cytology results and associated histological diagnoses from first year of screening (while aged 20), calculated using logistic regression. Results 138 692 records were retrieved. Compared with unvaccinated women born in 1988, vaccinated women born in 1995 and 1996 showed an 89% reduction (95% confidence interval 81% to 94%) in prevalent cervical intraepithelial neoplasia (CIN) grade 3 or worse (from 0.59% (0.48% to 0.71%) to 0.06% (0.04% to 0.11%)), an 88% reduction (83% to 92%) in CIN grade 2 or worse (from 1.44% (1.28% to 1.63%) to 0.17% (0.12% to 0.24%)), and a 79% reduction (69% to 86%) in CIN grade 1 (from 0.69% (0.58% to 0.63%) to 0.15% (0.10% to 0.21%)). Younger age at immunisation was associated with increasing vaccine effectiveness: 86% (75% to 92%) for CIN grade 3 or worse for women vaccinated at age 12-13 compared with 51% (28% to 66%) for women vaccinated at age 17. Evidence of herd protection against high grade cervical disease was found in unvaccinated girls in the 1995 and 1996 cohorts. Conclusions Routine vaccination of girls aged 12-13 years with the bivalent HPV vaccine in Scotland has led to a dramatic reduction in preinvasive cervical disease. Evidence of clinically relevant herd protection is apparent in unvaccinated women. These data are consistent with the reduced prevalence of high risk HPV in Scotland. The bivalent vaccine is confirmed as being highly effective vaccine and should greatly reduce the incidence of cervical cancer. The findings will need to be considered by cervical cancer prevention programmes worldwide.


Sign in / Sign up

Export Citation Format

Share Document